Fosun International LTD Ascendis Pharma A/S Transaction History

Fosun International LTD

  • $106 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019
SELL
$95.8 - $118.9 $7.16 Million - $8.88 Million
-74,689 Closed
0 $0
Q2 2019

Aug 12, 2019
BUY
$107.11 - $132.09 $777,939 - $959,369
7,263 Added 10.77%
74,689 $8.1 Million
Q1 2019

May 10, 2019
BUY
$62.15 - $129.99 $876,315 - $1.83 Million
14,100 Added 26.44%
67,426 $7.77 Million
Q3 2018

Nov 09, 2018
BUY
$63.77 - $76.28 $3.4 Million - $4.07 Million
53,326 New
53,326 $3.54 Million

Others Institutions Holding ASND

# of Institutions
244
Shares Held
58.8M
Call Options Held
250K
Put Options Held
377K
View Full List

About Ascendis Pharma A/S

ASND Quotes by TradingView
  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $7.83B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Fosun International LTD Portfolio

Follow Fosun International LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fosun International LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email